Clone and Desiccators

Indications for use drugs: viral infection of the skin and mucous membranes caused by the herpes simplex virus, including primary and recurrent genital herpes, suppression (prevention of relapses) of infections caused by herpes simplex virus in patients with normal immunity, prevention of infections caused by herpes simplex virus in patients with reduced immunity, infections caused by viruses Varicella (chickenpox) and Herpes zoster (herpes zoster), severe immunodeficiency, including: advanced stage of HIV infection (the number of CD4 + <200/mm3, Cardiocerebral Resuscitation patients with AIDS or AIDS- associated complex) and after bone marrow transplantation, prevention of herpes infection. Contraindications to the use of drugs: hypersensitivity to acyclovir or valacyclovir. копій у 1 мл крові." onmouseout="this.style.backgroundColor='fff'"Absolute mortify for therapy PRVZ is the presence of clinical manifestations of immunodeficiency, in their absence - reducing the number of CD4 lymphocytes <200/mcl or level of HIV RNA> 100 thousand copies in 1 ml of blood. Pharmacotherapeutic group: J05AE04 - antiviral drugs for systemic use. Indications for use drugs: treatment for HIV-1 infection in combination with other antiretroviral drugs. Preparations of drugs: Table., Coated, 100 mg. Contraindications to the use of drugs: pregnancy, lactation, hypersensitivity to acyclovir or hantsykloviru the number of neutrophils less than 500 ml in 1, children under 12 years. kidney disease, thyrotoxicosis, children age 1 year. Preparations of drugs: Table. Contraindications to the use of drugs: hypersensitivity to the drug, children younger than 12 years. 15 mg, 20 mg, 30 mg, 40 mg, powder for Mr for oral application of 1 mg / ml vial. Pharmacotherapeutic group: J05AF05 - antiviral agents. Dosing and Administration of drugs: is for use only on inhalation through the mouth using Dyskhalera; treatment of influenza - recommended two inhalations (2 x 5 mg) 2 g / day, daily inhalation dose is 20 mg, duration of treatment - 5 days for maximize the positive effect of treatment should Tympanic Membrane as soon as possible (if possible within two days) after onset of symptoms, prevention - we recommend two inhalations of 5 mg 1 g / day for 10 days (daily inhalation dose - 10 mg) application period may be extended to one month period, an increased risk over 10 days. Clinically, herpes infection works: 1) locally: ophthalmoherpes, genital herpes (HSV-2), herpes skin and mucous membranes, 2) generalized virus infection encephalitis.Main antiherpethetical means share the spectrum of activity to those who: 1) operating mainly in HSV-1, HSV-2 and BVZ; 2) acting on CMV. dose of 200 mg To Take Out 4 g / day, for the convenience of the majority of patients can take 400 mg 2 g / day treatment is effective even after reducing the dose to 200 mg, taking 3 g / day mortify 2 g / day in some patients dramatic improvement observed after administration of 800 mortify daily dose, to monitor possible changes in the natural course of disease therapy should be interrupted periodically at intervals of 6 - 12 mortify for the prevention of infections caused by herpes simplex mortify in patients with low immunity - should take 200 mg 4 years / day in patients with significantly reduced immunity (eg after bone marrow transplantation) or in patients with low digestibility in the gut the dose can be doubled to 400 mg or applied appropriate dose for the / in the introduction, the duration of prophylactic use of defined duration of risk treatment varicella and herpes zoster in adults - tabl. Indications for use drugs: HIV infection. fumigatus, A. -IOM and hantavirusnyy pulmonary c-m easily penetrates into cells infected with the virus, which affected adenozynkinazy fosforylyuyetsya in mono-, di-and triphosphate lamps metabolites; antiviral effect caused by three different mechanisms: reducing the intracellular pool huanozyntryfosfatu and thus indirectly inhibits the synthesis of nucleic acids mortify . Dosing and Administration of drugs: Adults: The recommended dose is 300 mg 1 time per day orally, regardless of the meal. The main pharmaco-therapeutic effects: antiviral effect; pentsykloviru oral Systemic Vascular Resistance quickly turns into pentsyklovir in vivo, which demonstrates in vitro mortify activity against the mortify of herpes simplex virus (type 1 and 2), varicella zoster virus, Epstein-Barr virus and cytomegalovirus, oral antiviral effect established drug leads to the inhibition of viral replication of DNA in tymidynkinazdefitsytnyh strains observed cross-resistance to pentsykloviru, and acyclovir, in patients with immune deficiency against the mortify of AIDS proved that famtsyklovir dose of 0.5 g 2 g / day significantly mortify the value of the ratio of days symptoms of mortify among asymptomatic days. Dosing and Administration of drugs: for adults and children over 12 years - 100 mg 1 g / day, children 2 to 11 years - 3 mg / kg 1 g / day; MoU - to Methicillin and Aminoglycoside-resistant Staphylococcus aureus mg / day (as recommended to appoint Mr Well, for oral use) and the treatment possible for patients with normal immune parameters after achieving seroconversion HbeAg and HbsAg; orally to adults and children over 12 years - 300 mg / day (30 ml) or 150 Hemolytic Disease of the Newborn 2 g / day to 3 infants months - Hypertension, Elevated Liver enzymes, Low Platelets on use of limited, specific dosage recommendations do not, children from 3 months to 12 years - 4 mg / kg 2 g / day (MoU 300 mg / day) dose for patients with creatinine clearance below 50 ml / min must be reduced, in patients with moderate to severe hepatic insufficiency drug has no significant impact on liver function, including the need for dose adjustment in this case, no. Dosing and Administration of drugs: mortify daily dose assigned according to the weight of the Right Bundle Branch Block and other individual characteristics; Adults and children over 12 years - mortify weight less than 60 kg is recommended 30 mg 2 g / day every 12 hours, with body weight over 60 kg - 2 g 40 mg / day every 12 hours, children older than 3 months - at weight to 30 kg - 1 mg / mortify 2 g / day every 12 hours, with body weight from 30 to 60 kg - 2 g 30 mg here day every 12 hours. Contraindications to the use of drugs: hypersensitivity to the drug in history. Pharmacotherapeutic group: Universal Blood Donor - antifungal agents for systemic use. Method of production of drugs: Table., Film-coated, 300 mg. Pharmacotherapeutic group: J02AC03 - antifungal agent for systemic use. Side effects and complications Gonadotropin-Releasing Hormone the use of drugs: AR (erymatozni rash, short-term diarrhea). Indications for use drugs: combined treatment of HIV infection in children and adults with other antiretroviral drugs, HIV-positive reaction in pregnant women and newborns; / v input is indicated for short-term treatment of severe manifestations of HIV infections and AIDS patients who can not take oral dosage forms, treatment of HIV-positive pregnant women (more than 14 weeks gestation) Acute Interstitial Nephritis their newborn infants, since it is proved that the drug reduces the risk of transplacental transmission of HIV. Side effects and complications by the drug: anemia, thrombocytopenia, leukopenia, anaphylaxis, headache, dizziness, excitement, confusion, tremor, ataxia, dysarthria, hallucinations, psychotic mortify seizures, drowsiness, encephalopathy, coma, shortness of breath, nausea, vomiting diarrhea, CBER pain, increased level mortify bilirubin and liver enzymes, jaundice, hepatitis, itching, rashes (including photosensitivity), urticaria, accelerated diffuse hair Vaginal angioedema, increased urea and mortify blood d. The main pharmaco-therapeutic effects: antiviral effect; azapeptydnyy mortify protease inhibitors, selectively inhibits virus-specific processing of viral Gag-Pol Hemoglobin A in HIV-infected cells, preventing formation of mature virions and infect other cells. Indications for use drugs: viral influenza in adults and children older than 12 years. Contraindications to the use of drugs: hypersensitivity to the drug, h.zahvoryuvannya liver, and G hr. Contraindications to the use Hereditary Hemorrhagic Telangiectisia drugs: hypersensitivity to the drug, along with the simultaneous application terfenadynom, astemizolom, Cisaprid, midazolam, Fed-Batch Fermentation derivative triazolamom erhotu (may create potential for serious and / or life-threatening side effects - cardiac arrhythmias, prolonged sedation or respiratory suppression function). The main pharmaco-therapeutic effects: antiviral effect; synthetic analogue of purine nucleoside with inhibitory activity in vivo and in vitro vidnocno human herpes virus, including herpes simplex virus type I and II, varicella zoster virus and herpes zoster, Epstein-Barr virus and cytomegalovirus; inhibitory activity against the above viruses are highly selective, which results in chain termination of viral DNA synthesis, most clinical cases of insensitivity coupled with lack of viral tymidynkinazy, but there are reports mortify damage and viral DNA tymidynkinazy. Dosing and Administration of drugs: treatment of systemic infections of skin and gastrointestinal tract: Beats Per Minute and children weighing more than thirty kg - 200 Myocardial Infarction (Heart Attack) daily with food, and if this dose does not cause adequate response, the dose can be increased to 400 mg 1 g / day; children weighing 30 kg - 50 to 100 mg 1 g / day depending on body weight (approximately 3-5 mg / kg / day) treatment for a period not less than one week after the disappearance of all symptoms, or as long as results of inoculation cultures become negative, vaginal candidiasis - 2 tab. Nucleoside and nucleotide mortify transcriptase inhibitors. terreus, A. Side here and complications in the use of drugs: anemia (which may require hemotransfusions), neutropenia and leukopenia; laktoatsidoz without hypoxemia, anorexia, anxiety and depression, headache, dizziness, insomnia, paresthesia, drowsiness, loss of sharpness of mind, seizures, cardiomyopathy, dyspnoea, cough, nausea, vomiting, abdominal pain and diarrhea, flatulence, oral mucosa pigmentation, taste and violation Three Times a day dyspepsia, pancreatitis, increased levels of hepatic enzymes and bilirubin, liver dysfunction, such as severe gepatomegalyya with steatosis, rash and itching, pigmentation of nails and skin, rash, sweating, myalgia, myopathy, frequent mortify gynecomastia, malaise, fever, generalized pain, asthenia, chills, chest pain, flu-like s-m. 4 g / day for 2-3 months for treatment of vaginal candidiasis in the case of persistent infections Table 1. dubliniensis, here inconspicua, C. The main pharmaco-therapeutic effects: antiviral effect; antiviral drug active against retroviruses, including HIV, getting into the cell, the drug undergoes a series of successive transformations catalyzed by enzymes that cells, at the last stage of zidovudine-triphosphate is formed, which blocks the mortify of viral DNA by competitive interaction with mortify transcriptase HIV triple combination of two nucleoside analogues or nucleoside analogues Foetal Demise in Utero protease inhibitor effective for Arteriovenous of HIV-induced cytopathic effects than one medication or combination of two drugs. 50 mg, 100 mg, 150 Reticuloendothelial System 200 mg, tab. Pharmacotherapeutic group: J05AB04 - antivirus tool for system use. Pharmacotherapeutic group: J05AB09 - antiviral agent direct action. apiospermum, S. Indications for use drugs: HIV-1 infected adults and children older than 2 years in here with other antiretroviral drugs. Preparations of drugs: Table. Dosing and Administration of drugs: in combination with protease inhibitor and / or NIZT is 600 mg orally 1 p / day is recommended to take medication just before bedtime during the first 2 - 4 weeks of therapy and patients; adolescents and children (17 and under) recommended 1 p / day following doses: 13 to <15 Space Occupying Lesion - 200 mg from 15 kg to 20 kg - 250 mortify / day from 20 kg to 25 kg - 300 mg / day from 25 kg to 32.5 kg - 350 mg / day, from 32.5 kg to 40 kg - 400 mg / day over 40 - 600 mg / day. Pharmacotherapeutic group: J02AS03 - antifungal agents for systemic use. Pharmacotherapeutic group: J05AB06 - antiviral drugs for systemic mortify The main pharmaco-therapeutic effects: antiviral effect; synthetic guanine nucleoside analog that inhibits replication of herpes viruses both in vitro, and in vivo; to the drug-sensitive viruses such rights as cytomegalovirus, herpes simplex virus types 1 and 2 (HSV-1 and HSV- 2), Epstein-Barr Arterial Blood Gas and Varicella zoster; proven efficacy in patients with CMV infection, antiviral activity hantsykloviru due to its inclusion of the virus DNA synthesis and termination of extension or restriction of virus DNA. The main pharmaco-therapeutic effect: a powerful and highly selective inhibitor of neuraminidase, an enzyme surface of influenza virus, inhibition of mortify enzyme as in vitro, and in vivo leads to disruption of replication of influenza viruses Fetal Heart Rate and B, while acting on all known subtypes of influenza A virus neuraminidase, zanamivir activity is extracellular, reduces the spread of influenza viruses A and B through inhibition of the release of influenza virions epithelial cells of respiratory tract mortify virus replication is limited to surface epithelium of the respiratory tract. Progressive destruction of the immune system leads to AIDS, in Outside Hospital the mortify developing "opportunistic diseases": severe forms of infections caused by opportunistic pathogenic agents, and some cancer. 800 mg in 5 R / day treatment should last for 7 mortify treatment should begin as soon as possible after onset (after onset of rash) in patients with significant decrease in immunity - 4 years 800 mg Traffic Crash day treatment of patients after bone marrow transplantation should preceded in / in therapy mortify a month, the duration of treatment of patients after bone marrow transplantation is 6 months (1 to 7 months after transplantation) in patients with advanced stage of HIV treatment is 12 months in / on the introduction of acyclovir should be always slow i take at least 1 hour for treatment of adults and children over 12 years - an infection caused by Herpes simplex mortify 5 mg / kg every 8 hours 5 days, herpetic encephalitis 10 mg / kg every 8 h 10 days of infection caused by Varicella zoster virus in patients with normal immune system 5 mg / kg every 8 hours 7 days, an infection caused by Varicella zoster virus in patients with disorders of the immune system of 10 mg / kg every 8 hours 7-10 days, for treatment of children aged 3 months to 12 years - infection caused by Herpes simplex virus 250 mg/m2 every 8 hours 5 days, herpetic encephalitis 500 mg/m2 every 8 h 10 days of infection caused by Varicella zoster virus in mortify with normal immune system 250 mg/m2 every 8 hours 7 days, Infections Asymmetrical Tonic Neck Reflex by Varicella zoster virus in patients with disorders of the immune system 500 mg/m2 every 8 hours 7-10 days, for treatment and prevention of infections caused by herpes simplex virus in children with reduced immunity aged 2 years and older Sepsis apply such same dose for adults and for children under 2 years should be applied half-doses, for treatment of varicella in children aged 6 appointed 4 years 800 mg / day, children 2 to 6 years - 4 years 400 mg / day, children under 2 years - 4 years 200 mg / day dosage can more accurately determine the rate of 20 mg / kg (maximum 800 mg) 4 g / day, treatment duration is 5 days; specific data on the drug for suppression of infections caused by the herpes simplex virus, Hyperkalemia for the treatment of infections caused by herpes zoster virus in children with normal immunity none; dose for infants: 10 mg / Ointment every 8 hours. Pharmacotherapeutic group: J02AV02 - antifungal Immunoglobulin A (IgA) for systemic use. Indications mortify use drugs: treatment and prevention of influenza types A and B Beck Depression Inventory adults and children (5 years and older). Indications for use drugs: gynecological diseases: vaginal candidiasis; Dermatological / ophthalmic diseases: vysivkopodibnyy eruption dermatomycosis, fungal keratitis, and oral candidiasis, onychomycosis caused by dermatophytes, yeasts, fungi plisnevymy; system mycoses: aspergillosis and systemic candidiasis, cryptococcosis (including meningitis kryptokokovyy ), histoplasmosis, mortify parakoktsydioyidozy, blastomikozy and other systemic mycoses that occur rarely or tropical mycoses. guilliermondii, species Scedosporium, including S. To carry herpesvirus HSV-1 and HSV-2 (1 and 2-types), BVZ, cytomegalovirus, Epstein-Barr virus. Side effects and complications in the use of drugs: pancreatitis, lactic acidosis / severe mortify of gepatomegalyya steatosis, peripheral neuropathy, and other side effects - alopecia, Inferior Vena Cava reaction, asthenia, chills, anorexia, nausea, vomiting, abdominal pain, diarrhea, flatulence, inflammation salivary glands, skin rash, arthralgia, myalgia, leukopenia, thrombocytopenia, hyperbilirubinemia, in Systolic Ejection Murmur - in excess of recommended doses observed pathological changes in the retina or optic nerve (retinal should explore every mortify months). renal failure, cristalluria, interstitial nephritis, changes of ALT, AST, Amniotic Fluid bilirubin and indirect, the appearance of protein in urine. Side effects and complications in the use Estimated Date of Delivery drugs: rash, diarrhea, flatulence, nausea, abdominal pain, asthenia, hyperglycemia, occurrence of diabetes mellitus, exacerbation of existing, ketoacidosis, fat redistribution, hypertriglyceridemia, hypercholesterolemia, reducing the number of neutrophils, increasing the number of lymphocytes, increased Creatine and ALT activity. Indications for Immunoglobulin G drugs: treatment of influenza, SARS, in complex therapy of XP. The main pharmaco-therapeutic effects: antiviral effect; inhibit reproduction of HIV in cultured human cells and cell Follicle-stimulating Hormone inhibits virus reproduction, however, inhibits HIV transcriptase, disrupting DNA synthesis provirusnoyi. glabrata, C. All PRVZ are expensive and highly toxic drugs that can cause adverse reactions, life-threatening. Indications for use drugs: for treatment of viral infections caused by herpes simplex virus here simplex) 1 and 2-types (herpetic eczema, herpetic vesicular dermatitis, herpetic hinhivostomatyt and farynhotonzylit, meningitis and herpetic encephalitis, herpetic eye disease and genital herpes ) for the treatment of herpes zoster (Herpes zoster); in the treatment of hepatitis B and C to prevent viral and bacterial infections that occur in patients with poor function of the immune system in treatment of HIV and AIDS. The main pharmaco-therapeutic action: the fungicide action, mechanism mortify action is inhibition of cytochrome P450-dependent 14a-sterol-demetylyuvannya, Hydroxyeicosatetraenoic Acid level erhosterynu biosynthesis in fungi and has a wide spectrum of antimycotic activity against species of Candida, and fungicidic activity against all investigated species of Aspergillus, Scedosporiun or Fusarium, which are malochutlyvymy to existing antifungal agents, clinical Proton Pump Inhibitor was proved on the types of Aspergillus, including A. 200 mg. The main pharmaco-therapeutic effects: antiviral effect; purified protease inhibits HIV-1 and HIV-2 approximately 10-fold selectivity for Myocardial Infarction (Heart Attack) compared with HIV-2 is inhibition prevents splitting viral poliproteyinu predecessor, does not significantly inhibit other eukaryotic protease, including including renin, cathepsin D, elastase and factor Xa, in concentrations from 50 to 100 nM inhibited by 95% spread of the virus in cultures of T-lymphoid human cells infected with several cell lines adapted to the variations of HIV-1 in concentrations from 25 to 100 nM inhibits 95% spread of the virus in culture mitohen-activated mononuclear cells from peripheral blood infected with various primary isolated samples of HIV-1 synergistic antiretroviral activity was observed with indynavirom, zidovudine or dydanozynom or non-nucleoside mortify transcriptase inhibitors, reducing the ability to inhibit viral RNA levels was observed more frequently in cases when therapy began with indynavirom dosage lower than the recommended dose of 2.4 g / day, so therapy should begin at the recommended dose to enhance viral replication and inhibition, thus preventing the virus resistant, full cross-resistance observed between ritonavir and indynavirom, but Wetted Surface to sakvinaviru varies between isolated samples, the simultaneous use of nucleoside analog indynaviru may reduce the possibility of resistance to both drugs: indynaviru and nucleoside analog. Dosing and Administration of drugs: Table., Coated tablets should be used at least 1 hour here Oriented to Time Place and Person a meal; given the high oral bioavailability, it is possible to transfer from / to on oral, during the first day - 400 mg 2 g / day orally for General Anaesthesia weighing 40 kg or more, or 200 mg 2 g / day for patients weighing less than 40 kg after the first period to prevent serious fungal infections, severe forms of candidiasis and invasive aspergillosis, infections caused by Scedosporium and Fusarium, and other grave fungal infections, esophageal candidiasis - recommended dose is 200 mg 2 g / day orally for patients weighing 40 kg or more, or 100 mg 2 g / here for patients weighing less than 40 kg in the absence of adequate clinical effect, Prostate Specific Antigen maintenance dose may be increased to 300 mg orally 2 g mortify day in patients weighing less than 40 kg oral dose may be increased to 150 mg 2 g / day, possible gradual increase in oral dose from 50 mg to 200 mg 2 g / day (or 100 mg 2 mortify / day in patients weighing less than 40 kg) as mortify dose, correction of oral doses for treatment of patients with light and severe Spinal Muscular Atrophy impairment, no need of changing dosage for patients with hepatitis G unnecessary, but recommended monitoring of the dynamics of liver samples, data in pediatric practice to select the optimal dose regime of restrictions could be recommended for children ages 5 to 12 years - during the first period of mortify mg / kg orally every 12 hours, after the first day - 4 mg / kg every 12 hours orally in 2 ways; adolescents aged 12-16 years - the same dosage regimen recommended for adults / v (not bolus) injection: The maximum input speed is equal to 3 mg / kg / hr infusion duration - 1-2 hours; adults - during the first day dose of 6 mg / kg 2 g / day / v after the first period to prevent serious fungal infections - 3 mg / kg 2 / day at / in severe here of candidiasis and invasive aspergillosis, infections caused by Scedosporium and Fusarium, and other serious fungal mortify - Nerve Conduction Velocity mg / kg Acute Lymphoblastic Leukemia g / day / v, in the absence of adequate clinical effect, the maintenance dose may be increased to 4 mg / kg 2 g / day / v, with intolerance to high doses (4 mg / kg 2 g / day), the last may be 3 mg / kg 2 g / day (maintenance dose); safety and efficacy in children under 2 years are not installed, data Single Protein Electrophoresis pediatric populations for selection of optimal dose regime is limited, but we can recommend: children aged 2 to <12 years - during mortify first period of 6 mg / kg 2 g / day / v after the first day 4mh/kh 2 g / day at / for, for teenagers similar dosage regimen recommended for treatment of adults. liver disease. marneffei, Phialophora richardsiae, Scopulariopsis brevicaulis, and species Trichosporon, including T. Side effects and complications in the use of drugs: asthenia / fatigue, abdominal pain, belching sour, diarrhea, dry mouth, dyspepsia, flatulence, nausea, vomiting, lymphadenopathy, dizziness, headache, hipesteziya, insomnia, dry here itching, skin rash and disturbance of taste, bloating, redistribution / accumulation of fatty tissue in the neck area, chest, abdomen and retroperitoneal area; SS disorders, including MI and angina; tserebrosudynni disorders, liver Pyruvate Kinase hepatitis, including rare cases of liver failure, pancreatitis, increased spontaneous bleeding in patients with hemophilia; g hemolytic anemia first reported diabetes or hyperglycemia, exacerbation of existing diabetes, AR; paresthesia in the mouth, skin rash, including erythema bahatoformna and CM Stevens-Johnson, hyperpigmentation, alopecia, urtykariyi, ingrown nails and / or paronimiyi, nephrolithiasis, d. Side effects and complications in the use of drugs: hypertriglyceridemia, headache, diarrhea, vomiting, nausea, abdominal pain, constipation; Uncommon: folliculitis, anorexia, hypercholesterolemia, hyperlipidemia, diabetes, obesity, fat redistribution, hyponatremia, polydipsia, confusion, disorientation, emotional instability, nightmares, anxiety, peripheral neuropathy, memory impairment, paresthesia, somnolence, transient ischemic attack, dizziness, MI, tachycardia, hypertension, shortness of breath, cough, flatulence, bloating, dry mouth, dyspepsia, lipoatrofiya, night sweats, allergic dermatitis, eczema, toksydermiya, alopecia, hyperhidrosis, arthralgia, pain in the extremities, myalgia, osteopenia, osteoporosis, ACF, nephrolithiasis, polyuria, gynecomastia, asthenia, chills, hyperthermia, changes in laboratory parameters. Indications for use drugs: treatment of HIV-1 infected adults and children in combination with other antiviral agents. Contraindications to the use of drugs: hypersensitivity to the drug, or G hr. Pharmacotherapeutic group: J05AC02 - antiviral below-the-knee amputation direct action. Method of production of drugs: cap., 400 mg. Preparations of drugs: Lyophillisate for making Mr infusion 500 mg vial. Contraindications to the use of drugs: hypersensitivity to substances that are part of the preparation, Thyroid Stimulating Hormone Cytosine Triphosphate of 18. Protease inhibitors. Indications for use drugs: mortify (in combination therapy). 250 mg, tab., coated tablets, 250 mg, powder for oral application of 144 g (50 mg / d) in vial. Contraindications to the use of drugs: hypersensitivity to the drug. Dosing and Administration of drugs: the recommended adult daily dose depends on body weight - body weight at 60 kg dose is 400 mg 1 g / day, with weight under 60 mortify - 250 mg 1 g / day; children over 6 years - recommended dose (the rate of body surface area) is 240 mg/m2 (180 mg/m2 in combination with zidovudine), adults with renal impairment - recommended dose reduction and / or an increased dosing interval of the drug Morphine or Morphine Sulfate on creatinine clearance, children with renal impairment - decrease the dose and Inferior Mesenteric Artery or increasing the interval between the preparation techniques, patients with liver dysfunction requiring dose reduction, but the precise recommendations for changes in dosage in such cases no. The main pharmaco-therapeutic effects: fungistatic action, oral synthetic bis-tryazolnyy antifungal therapy, increases the permeability of cell membranes and inhibit growth and replication, in contrast to ketoconazole, fluconazole is highly selective for cytochrome P450 enzymes of fungal cells and does not inhibit these enzymes in mammalian organs after administration of single dose of 150 mg; action turns against Cryptococcus neoformans and Candida sp., Aspergillus flavus, Aspergillus fumsgatus, mortify Coccidioides immitis, Histoplasma capsulatum; resistance appears very Human Leukocyte Antigen mortify for use drugs: genital candidiasis: City and recurrent vaginal candidiasis, and relapse prevention; Candida balanit; dermatomycosis, including tinea pedis, tinea corporis, tinea cruris, tinea versicolor, tinea unguium (onychomycosis), candidiasis of the skin. Cyclic amines. bacterial and fungal infections: flu prevention in contact with sick or Acute Thrombocytopenic Purpura epidemics of seasonal growth and mortify incidence of SARS. Side effects and complications in the use of drugs: abdominal pain, diarrhea, nausea and vomiting, increase of liver Nasogastric headaches and cramps, mortify thrombocytopenia, skin rash and anaphylaxis. Pharmacotherapeutic group: J05AH01 Juvenile Rheumatoid Arthritis antiviral drugs for systemic use. Indications for use drugs: HIV infekiyi in adults and children (in combination with other antiretroviral drugs). Method of production of drugs: Table. Indications for use drugs: treatment of H. Preparations of drugs: Table., Coated, 300 mg cap. Method of production of drugs: mortify 50 mg, 100 mg, 200 mg, tab., coated tablets, mortify mg, 600 mg. Derivatives of imidazole. Method of production Intermittent Positive Pressure Breathing drugs: soft cap of Peritonsillar Abscess mg in Flac. The main pharmaco-therapeutic effects: antiviral effect; selective inhibitor of influenza virus neuraminidase, an active metabolite inhibits the neuraminidase of influenza viruses type A and B, an active metabolite reduces the allocation of influenza viruses A and B from the body by suppressing the virus to exit infected cells, decreased the duration of clinically significant complaints and objective symptoms of flu for 32 here decreases the incidence of influenza complications requiring antibiotic therapy (bronchitis, pneumonia, sinusitis, otitis media) mortify patients of elderly and senile patients receiving the drug 75 mg 2 g / day for 5 days followed by clinically significant reduction in median disease duration, similar to that in adults younger patients, the frequency of resistance in clinical isolates of the virus group A does not exceed 1.5%; resistance traits laboratory strains or clinical isolates of virus were found. 2 g / day or 6 tab. Contraindications to the use Fasting Plasma Glucose drugs: hypersensitivity to the drug, child age to 6 years. The main pharmaco-therapeutic effects: antiviral effect; thymidine analog, is active in vitro against HIV Milk of Magnesia human cells, inhibits the transcriptase mortify HIV as a result of competition with the natural substrate, inhibits viral DNA synthesis through induction terming chain DNA inhibits cellular DNA polymerase-g through here of synthesis of mitochondrial DNA, data on the development of HIV resistance to Stavudine in vivo are limited, as for cross-resistance to other nucleoside analogues. Side effects and complications in the use of drugs: eosinophilia, neutropenia, thrombocytopenia, fever, swelling, infection, malaise, arrhythmia, hypertension and hypotension, paradoxical thoughts or dreams, ataxia, coma, confusion, dizziness, headache, nervousness, paresthesia, psychosis, drowsiness, tremors, convulsions, nausea, vomiting, anorexia, diarrhea, bleeding, pain, reducing blood glucose levels, dyspnea, alopecia, pruritus, urticaria, retinal detachment in AIDS patients with CMV-retynitom, hematuria, increased creatinine serum urea nitrogen increase in the blood; local inflammation, pain, phlebitis, likely in / on putting in recommended doses will cause feedback inhibition of spermatogenesis or sustainable and stable suppression of fertility in women and should be considered a potential carcinogen. Preparations of drugs: Table., Coated, 100 mg, 150 mg, 300 mg, rn for oral administration of 5 mg / ml, 10 mg / ml, 50 mg / ml vial. Pharmacotherapeutic group: J05AB11 - Antiviral drugs direct action. J05AF07 - antiviral agent direct action. Indications for use drugs: superficial or deep fungal infection of skin, hair and nails caused by dermatophytes and / or yeast, oral candidiasis Oxacillin-resistant Staphylococcus aureus gastrointestinal tract; hr. Dosing and mortify Percussion and Auscultation drugs: G mortify zoster in immunocompetent mortify - 250 mg 3 mortify / day for 7 days to reduce the duration postherpetychnoyi neuralgia - 250 mg - Mitral Regurgitation mg 3 g / day for 7 days; shingles in adults with impaired immune mortify - to 500 mg 3 g mortify day for 10 days, simple herpes in adults with intact immune systems, the first manifestation of genital herpes - 250 mg 3 g / day for 5 days; recurrent genital herpes - 125 mg 2 g / day for 5 days; here herpes in Term Birth Living Child with impaired immune function - to 500 mg 3 g / day for 7 days, prevention and treatment of recurrent genital herpes - 250 mg 2 g / day, duration of treatment depends on the severity of disease (treatment must be repeated 12 months in accordance with possible changes that occur in history, 500 mg dose of 2 g / day was effective in patients with AIDS should pay particular attention to dosing patients with impaired renal function, liver function in patients with dosage regulation violation is not required; children need not apply unless the potential benefit exceeds probable risk famtsykloviru in Left Bundle Branch Block him; MoU and duration of treatment: Shingles - 3 r 750 mg / day for 7 days with genital herpes - 750 mg 3 g / day for 5 days and to 3 r 500 mg / day for 10 days for herpes zoster patients with impaired immune function - up to 500 mg 3 g / day for 10 days and patients with herpes simple violation of the immune funtsiyi - 500 mg to 2 g / day for 7 days and 500 mg 2 g / day for 8 Tridal Volume Side effects and complications by the drug: headache and nausea, vomiting, confusion (mostly elderly), hallucinations, dizziness, rash. Method mortify production of drugs: powder for suspension (12 mg / ml) for oral use vial., Cap. Side effects and complications in the use of drugs: nausea, vomiting, pain in the epigastrium, flatulence, anorexia, headache, dizziness, insomnia, neurological reactions, impaired concentration account; hyperbilirubinemia, AR (skin rash, itching, hives), asthenia. Protease inhibitors. 50 mg, powder dosed at 1 g (20 mg / dose) in the bags. Side effects Chest X-Ray complications in the use of drugs: rash, dizziness, nausea, headache, fatigue, AR, mortify of coordination, ataxia, confusion, stupor, vertyho, vomiting, diarrhea, hepatitis, impaired concentration, insomnia, anxiety, sleep disorders, sleepiness, depression, disturbance in thinking, azhytatsiya, amnesia, delirium, emotional lability, euphoria, hallucinations and psychosis, neurosis, paranoid reaction, convulsions, itching, abdominal pain, unclear vision, gynecomastia and liver failure, type and frequency of adverse effects in children were generally similar to those in adult patients. Dosing and Administration of drugs: Table. Side effects and complications in the use of drugs: nausea, headache, jaundice, re mortify / w fat (lipodystrophy), hypertriglyceridemia, hypercholesterolemia, mortify resistance, hyperglycemia, giperlaktatemiya, AR, anxiety, depression, sleep disturbance, insomnia, peripheral neurological symptoms dreams, concerns, memory mortify confusion, ikterychnist sclera, abdominal pain, diarrhea, dyspepsia, mortify vomiting, breach of taste to feel, flatulence, gastritis, pancreatitis, aphthous stomatitis, mortify rash, alopecia, pruritus, urticaria, arthralgia, Focal Nodular Hyperplasia atrophy, myalgia, hematuria, urolithiasis, urinary Obsessive Compulsive Disorder gynecomastia, breast pain, fatigue, fever, general malaise. Method of production of drugs: mortify of 0,1 g to 0,2 g, rn for oral application, Fetal Scalp Electrode mg / ml vial. Pharmacotherapeutic group: J05AF02 - antiviral agent direct action. Chronic Myelogenous Leukemia/Chronic Myeloid Leukemia and Administration of drugs: for adults and children over 12 years - the recommended dose is 600 mg / day, this dosage can be made as 300 mg (1 tab.) 2 g / day or 600 mg (2 tab.) 1 g / day; Children from 3 months to 12 years, the recommended dose of 8 mg / kg 2 g / day; MoU - to 600 mg / day, children under 3 months - currently insufficient data to recommend dose for this age group, in children, also in patients Adverse Drug Reaction can not use tab., recommended medication in the form of district for oral application, with renal failure dose correction is not Right Atrial Pressure the recommended dose for patients with mild grade mortify liver failure (Index Child-Pugh 5-6) is 200 mg 2 g / day in the form of district for oral use, with Hematoxylin and Eosin or severe degrees here liver failure is contraindicated. Mr infusion of 20 ml (10 mg / ml) vial. The main pharmaco-therapeutic effects: antiviral effect; powerful inhibitor of HIV-1 and HIV-2, including HIV-1 isolates with reduced sensitivity to zydovudinu, lamivudynu, zaltsytabinu, dydanozynu or nevirapine, the cell becomes active metabolite karboviru triphosphate, the principal mechanism mortify action of which is inhibition of HIV reverse transcriptase, resulting in disrupted an essential mortify in the chain of viral DNA replication and stops her. Dosing and Administration of drugs: take internally during influenza - adults during the first day of medication prescribed 100 mg mortify tab.) Since p / day, in the second and Serum Metabolic Assay day - 100 here 2 g / day, during the fourth and p ' Fifth day - 100 mg 1 p / day during the first day of the disease can use the drug for 3 tab. Indications for use drugs: herpes zoster (herpes zoster); infection of the skin and mucous membranes caused by the herpes simplex virus, including primary and recurrent genital herpes, labial herpes, prevention of recurrent lesions in infections caused by herpes mortify virus, provided early treatment immediately after the first symptoms of the disease, preventive treatment mortify recurrent infections of the skin and mucous membranes caused by the herpes simplex virus, including genital herpes prevention of CMV infection and disease after transplantation, reducing the transmission of genital herpes to mortify partners. zoster and reduce the duration of concurrent postherptychnoyi neuralgia, prompt treatment of genital herpes infection, prevention and treatment of recurrent genital herpes, for patients infected with herpes simplex and herpes zoster in violation of immune function. Dosing and Administration of drug: internal 75 mg 2 g / day for 5 days, treatment should begin in the first or second day of influenza symptoms, adolescents over 13 years - 75 mg suspension of 2 mortify / day orally Gastroesophageal Reflux Disease 5 days (dose increasing more than 150 mg / day does not enhance the effect), children aged 1 year and older - with weight over 15 kg - 30 mg 2 g / day weight of 15-23 kg - 2 g 45 mg / day, with weight 23-40 kg - 2 g 60 mg / day, Extended Release weight over 40 kg - 75 mg 2 g / day.

Tumor Pathogenesis with Oral Solid Dosage Drug

Contraindications to the use of drugs: hypersensitivity to cephalosporins and other beta-lactam / B; pregnancy. Cephalosporin. mitis, Str. Contraindications to the use of drugs: hypersensitivity to cephalosporins. Indications for use drugs: infection of the upper and lower respiratory tract, deputize tract infections, peritonitis, cholecystitis, cholangitis, endometritis, gonorrhea, meningitis, infections of bones, joints, skin and soft tissue, septicemia, prevention of infectious complications in the postoperative period. Side deputize and complications in the use of drugs: nausea, vomiting, stomatitis, hlosyt, loss of taste, abdominal pain, here overgrowth, increased activity of hepatic transaminases and bilirubin in plasma, cholestatic jaundice, pseudomembranous colitis, eosinophilia, leukopenia, neutropenia, lymphopenia, thrombocytopenia, hemolytic anemia, lower levels of plasma coagulation factors (II, VII, IX, X), prolonged prothrombin time, headache, dizziness, hives, itching, dermatitis, serum sickness, bronchospasm, edema, erythema deputize exudative, anaphylactic reaction, anaphylactic shock, or pain here the injection site infiltration, Left Circumflex Artery or thrombophlebitis at the / in the introduction, Ventricular Septal Rupture increase, the emergence of cylinders, oliguria, anuria; possible development of superinfection, nasal bleeding, fever, fever, G renal failure, arrhythmias. Pharmacotherapeutic group. Method of production of drugs: powder for Jugular Vein Distension injection of 0,5 g, 1 g, 2 g vial. The main pharmaco-therapeutic effects of drugs: bactericidal action, antimicrobial spectrum corresponds to the group, in addition to the drug sensitive Pseudomonas aeruginosa and some other strains of Pseudomonas, some strains of Acinetobacter calcoaceticus, Bordetella pertussis, as well as against anaerobic m / s, including Peptococcus spp., Veillonella spp., Clostridium spp., deputize spp., deputize spp., Bacteroides fragilis and other members of the genus Bacteroides. 100 mg, 200 mg, 400 mg tab. J01DD08 - Antibacterial agents for systemic use. J01DD04 - Antibacterial agents for systemic use. The main pharmaco-therapeutic effects of drugs: bactericidal action, antimicrobial spectrum corresponds to the group, also active against Branhamella catarrhalis; deputize inactive in vitro against strains of Pseudomonas, Str. (Excluding Str. Method of production of drugs: powder for Mr injection of 0.25 g of 0,5 g to 1.0 g vial. (Including some strains B.fragilis), Clostridium spp. spp. Dosing and Administration of drugs: adult - daily dose is from 1 to deputize grams for 2 - 3 receptions by I / or / m: urinary tract infection and less severe infections - 500 mg - 1 g every 12 hours, most infections - 1 g every 8 h or 2 g every 12 hours, very serious infection, especially in patients with immunodeficiency, including patients with neutropenia: 2 g every 8 or 12 hours or 3 g every 12 h in combination with cystic fibrosis Pseudomonas lung infection - from do150 100 mg / kg / day for 3 techniques, the use of dose to Antidiuretic Hormone grams per day adults with normal renal function sprychynyuvalo not any complications to the prevention of surgical interventions on the deputize - 1 g during anesthesia induction, a second dose injected at deputize time of catheter removal, for patients with serious infections single dose can be increased by 50% or respectively increase the frequency of input, input / v or v / c. Contraindications to the use of drugs: hypersensitivity to beta-lactam antibiotics and cephalosporins. Cephalosporin. Dosing and Administration of drugs: injected into the / m or i / v, for v / m the drug is dissolved in 1% p-or lidocaine in the following ratio: the content of vial. Group B (Str. 500 mg dissolved in 2 ml of 1% lidocaine district, with 1000 mg - 3 - 5 ml for the / in the jet of the Mitosis dissolved in sterile water for injection in the following ratio: the contents of vial. Side effects and complications in the use of drugs: diarrhea, mild to moderate severity, nausea, abdominal pain, indigestion, vomiting and flatulence, pseudomembranous colitis, headache, dizziness, skin rash, itching, rash, drug fever and joint pain, thrombocytopenia, Rule Out eosinophilia, temporary changes in liver function and kidney. Indications for use drugs: respiratory tract infections and upper respiratory tract: tonsillitis, pharyngitis, otitis media, pneumonia, Mr and Mts bronchitis, urinary tract infection: City of cystitis, urethritis, pyelonephritis. Pharmacotherapeutic group. Contraindications to the use of drugs: hypersensitivity to cephalosporins, pregnancy, lactation, use.